Rappel de Device Recall Boston Scientific Synchro 2 Guidewire

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Boston Scientific Corporation.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    56388
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-0872-2011
  • Date de mise en oeuvre de l'événement
    2010-06-07
  • Date de publication de l'événement
    2011-01-07
  • Statut de l'événement
    Terminated
  • Pays de l'événement
  • Date de fin de l'événement
    2011-01-10
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Wire, guide, catheter - Product Code DQX
  • Cause
    The guidewire has the potential to flake off polytetrafluroethylene (ptfe) particulate, which has the potential to embolize and result in infarction when introduced into a patient's circulatory system.
  • Action
    Boston Scientific Corporation sent an Urgent Medical Device Recall letter dated June 7, 2010, by Federal Express to all customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately discontinue use of and segregate the affected product. Complete and return the Reply Verification Tracking Form even if they did not have any affected product. Contact the Customer Service Call Center to obtain a Returned Goods Authorization (RGA) Number at (800) 811-3211, Option #1. E-mail or Fax the completed and signed Reply Verification Tracking Form to email Bob.Ware@bsci.com or the Field Action Fax (510) 624-2475. PackageShip and return the affected product along with the original Reply Verification Tracking Form by Federal Express to: Boston Scientific Corporation US Distribution Center Boston Scientific Marina Bay Customer Fulfillment Center 500 Commander Shea Blvd. Quincy, Massachusetts 02171 RGA: ____________ For questions regarding this recall call (510) 624-2563.

Device

  • Modèle / numéro de série
    Material # M00326410: lot/use by dates: B17096 7/31/2011  B17097 7/31/2011  B17098 7/31/2011  B17099 7/31/2011  B17185 7/31/2011  B17186 7/31/2011  B17187 7/31/2011  B17188 7/31/2011  B17198 7/31/2011  B17199 7/31/2011  B17287 7/31/2011  B17288 7/31/2011  B17327 8/31/2011  B17328 8/31/2011  B17329 8/31/2011  B17330 8/31/2011  B17331 8/31/2011  B17390 8/31/2011  B17391 8/31/2011  B17392 8/31/2011  B17393 8/31/2011  B17394 8/31/2011  B17469 8/31/2011  B17470 8/31/2011  B17472 8/31/2011  B17473 8/31/2011  B17474 8/31/2011  B17504 8/31/2011  B17507 8/31/2011  B17508 8/31/2011  B17509 8/31/2011  B17510 8/31/2011  B17602 9/30/2011  B17664 9/30/2011  B17665 9/30/2011  B17714 9/30/2011  B17715 9/30/2011  B17716 9/30/2011  B17717 9/30/2011  B17718 9/30/2011  B17719 9/30/2011  B17825 10/31/2011  B17826 10/31/2011  B817851 9/30/2011  B17931 10/31/2011  B17932 10/31/2011  B17933 10/31/2011  B17934 10/31/2011  B17984 10/31/2011  B17985 10/31/2011  B17986 10/31/2011  B17987 10/31/2011  B18003 10/31/2011  B18004 10/31/2011  B18082 10/31/2011  B18198 11/30/2011  B18200 11/30/2011  B18201 11/30/2011  B18202 11/30/2011  B18259 11/30/2011 B18260 11/30/2011  B18261 11/30/2011  B18266 11/30/2011  B18267 11/30/2011  B18268 11/30/2011  B18315 11/30/2011  B18316 11/30/2011  B18317 11/30/2011  B18318 11/30/2011  B18319 11/30/2011  B18394 12/31/2011  B18444 12/31/2011  B18445 12/31/2011  B18446 12/31/2011  B18447 12/31/2011  B18448 12/31/2011  B18449 12/31/2011  B18479 12/31/2011  B18480 12/31/2011  B18481 12/31/2011  B18484 12/31/2011  B18535 12/31/2011  B18536 12/31/2011  B18537 12/31/2011  B18538 12/31/2011  B18701 12/31/2011  B18742 1/31/2012  B18743 1/31/2012  B18812 1/31/2012  B18813 1/31/2012  B18814 1/31/2012  B18815 1/31/2012  B18816 1/31/2012  B18841 1/31/2012  B18842 1/31/2012  B18934 1/31/2012  B18987 2/29/2012  B18988 2/29/2012  B19023 2/29/2012  B19024 2/29/2012  B19110 2/29/2012  B19120 2/29/2012  B19187 3/31/2012  B19346 3/31/2012  B19379 3/31/2012  819384 3/31/2012
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution - USA including CA, CO, IN, MD, MI, OR, TX, and VA and the countries of Australia, Austria, Belgium, Canada, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Great Britian, Greece, Honduras, Hong Kong, India, Ireland, Israel, Italy, Japan, Kuwait, Lebanon, Lithuania, Malaysia, Netherlands, New Zealand, Norway, Panama, Poland, Portugal, Puerto Rico, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Sweden, Switzerland, Thailand, Tunisia, Turkey, and Ukraine.
  • Description du dispositif
    Boston Scientific brand Synchro2 0.14" Guide Wire, 200 cm, Standard; || Boston Scientific Corporation: Made in 2405 West Orton Circle, West Valley City, UT 84119 || Product is distributed by Boston Scientific Corporation, || Fremont, CA || The Synchro guidewire series is intended for general intravascular use, including neurovascular and peripheral vasculatures. It can be used to selectively introduce and position catheters and other interventional devices within the peripheral and neurovasculature. This device should be used only by physicians trained in percutaneous intravascular techniques and procedures.
  • Manufacturer

Manufacturer

  • Adresse du fabricant
    Boston Scientific Corporation, 47900 Bayside Pkwy, Fremont CA 94538-6515
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    USFDA